Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (58)

2024

  1. Edoxaban treatment in a post-infarction experimental model

    European Journal of Pharmacology, Vol. 962

2023

  1. Gastric GDF15 levels are regulated by age, sex, and nutritional status in rodents and humans

    Journal of Endocrinological Investigation

2022

  1. A genome-wide cell-free DNA methylation analysis identifies an episignature associated with metastatic luminal B breast cancer

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

    Cells, Vol. 11, Núm. 8

2021

  1. Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer? (Virchows Archiv, (2021), 479, 4, (853-857), 10.1007/s00428-021-03104-7)

    Virchows Archiv

  2. Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?

    Virchows Archiv, Vol. 479, Núm. 4, pp. 853-857

2020

  1. An energy restriction-based weight loss intervention is able to reverse the effects of obesity on the expression of liver tumor-promoting genes

    FASEB Journal, Vol. 34, Núm. 2, pp. 2312-2325

  2. Laser-induced transient skin disruption to enhance cutaneous drug delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 156, pp. 165-175

  3. Looking for a better characterization of triple-negative breast cancer by means of circulating tumor cells

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2018

  1. Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    Clinical and Translational Oncology, Vol. 20, Núm. 7, pp. 815-826

  2. Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis

    Virchows Archiv, Vol. 472, Núm. 2, pp. 195-203

  3. Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia

  4. Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology (Clinical and Translational Oncology, (2018), 20, 7, (815-826), 10.1007/s12094-017-1800-5)

    Clinical and Translational Oncology

  5. Effects of dapagliflozin on human epicardial adipose tissue: Modulation of insulin resistance, inflammatory chemokine production, and differentiation ability

    Cardiovascular Research, Vol. 114, Núm. 2, pp. 336-346

  6. Immunohistochemical assay for neuron-specific enolase, synaptophysin, and RB-associated protein as a diagnostic aid in advanced retinoblastomas

    Clinical Ophthalmology, Vol. 12, pp. 1171-1179

2017

  1. Liver metastasis is facilitated by the adherence of circulating tumor cells to vascular fibronectin deposits

    Cancer Research, Vol. 77, Núm. 13, pp. 3431-3441

  2. Obestatin controls the ubiquitin–proteasome and autophagy–lysosome systems in glucocorticoid-induced muscle cell atrophy

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 8, Núm. 6, pp. 974-990

2016

  1. Cell senescence is an antiviral defense mechanism

    Scientific Reports, Vol. 6

  2. Molecular Profiling of Circulating Tumour Cells Identifies Notch1 as a Principal Regulator in Advanced Non-Small Cell Lung Cancer

    Scientific Reports, Vol. 6

  3. The role of the obestatin/GPR39 system in human gastric adenocarcinomas

    Oncotarget, Vol. 7, Núm. 5, pp. 5957-5971